ID

31212

Description

A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).; ODM derived from: https://clinicaltrials.gov/show/NCT00760929

Link

https://clinicaltrials.gov/show/NCT00760929

Keywords

Versions (1)
  1. 7/29/18 7/29/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 29, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00760929

English

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00760929

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female patients >=18 years with histologically documented inoperable, locally advanced or metastatic (stage iiib or iv) nsclc;
Description

Age | Non-Small Cell Lung Carcinoma Advanced Locally Inoperable TNM clinical staging | Non-small cell lung cancer metastatic Inoperable TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C0205179
UMLS CUI [2,3]
C1517927
UMLS CUI [2,4]
C0205187
UMLS CUI [2,5]
C3258246
UMLS CUI [3,1]
C0278987
UMLS CUI [3,2]
C0205187
UMLS CUI [3,3]
C3258246
patients must have failed at least one but no more than two standard chemotherapy regimens;
Description

Chemotherapy Regimen Quantity failed

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
measurable disease according to the recist criteria;
Description

Measurable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
ecog performance status;
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy >12 weeks.
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with active cns lesions;
Description

Central nervous system lesion

Data type

boolean

Alias
UMLS CUI [1]
C0742468
prior treatment with agents acting via igf-1r inhibition or egfr targeting;
Description

IGF1R Inhibitors | Pharmaceutical Preparations Targeting EGFR

Data type

boolean

Alias
UMLS CUI [1,1]
C4044495
UMLS CUI [1,2]
C0243077
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C1521840
UMLS CUI [2,3]
C0034802
administration with high doses of systemic corticosteroids;
Description

CORTICOSTEROIDS FOR SYSTEMIC USE High dose

Data type

boolean

Alias
UMLS CUI [1,1]
C3653708
UMLS CUI [1,2]
C0444956
radiotherapy in the 4 weeks prior to study start;
Description

Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C1522449
surgery or significant traumatic injury with in the last 2 weeks prior to study start.
Description

Operative Surgical Procedures | Traumatic injury

Data type

boolean

Alias
UMLS CUI [1]
C0543467
UMLS CUI [2]
C3263723
Back to the top of the page

Similar models

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00760929

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Non-Small Cell Lung Carcinoma Advanced Locally Inoperable TNM clinical staging | Non-small cell lung cancer metastatic Inoperable TNM clinical staging
Item
male or female patients >=18 years with histologically documented inoperable, locally advanced or metastatic (stage iiib or iv) nsclc;
boolean
C0001779 (UMLS CUI [1])
C0007131 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C0205187 (UMLS CUI [2,4])
C3258246 (UMLS CUI [2,5])
C0278987 (UMLS CUI [3,1])
C0205187 (UMLS CUI [3,2])
C3258246 (UMLS CUI [3,3])
Chemotherapy Regimen Quantity failed
Item
patients must have failed at least one but no more than two standard chemotherapy regimens;
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
Measurable Disease
Item
measurable disease according to the recist criteria;
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status;
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy >12 weeks.
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Central nervous system lesion
Item
patients with active cns lesions;
boolean
C0742468 (UMLS CUI [1])
IGF1R Inhibitors | Pharmaceutical Preparations Targeting EGFR
Item
prior treatment with agents acting via igf-1r inhibition or egfr targeting;
boolean
C4044495 (UMLS CUI [1,1])
C0243077 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C1521840 (UMLS CUI [2,2])
C0034802 (UMLS CUI [2,3])
CORTICOSTEROIDS FOR SYSTEMIC USE High dose
Item
administration with high doses of systemic corticosteroids;
boolean
C3653708 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
Therapeutic radiology procedure
Item
radiotherapy in the 4 weeks prior to study start;
boolean
C1522449 (UMLS CUI [1])
Operative Surgical Procedures | Traumatic injury
Item
surgery or significant traumatic injury with in the last 2 weeks prior to study start.
boolean
C0543467 (UMLS CUI [1])
C3263723 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial